Prospectuve study on the treatment of normal tension glacuoma with selective laser trabeculoplasty
- Conditions
- ormal tension glaucomaTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Investigative Techniques [E05]
- Registration Number
- EUCTR2014-003305-15-Outside-EU/EEA
- Lead Sponsor
- HK Clinical Trials
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- A
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Newly diagnosed or existing NTG patients
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 20
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 20
Exclusion Criteria
Any previous glaucoma surgery or laser
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: Look at the effects of IOP reduction using SLT in the treatment of NTG. ;Secondary Objective: Look at the effects of IOP reduction using SLT in the treatment of NTG. ;Primary end point(s): Baseline IOP without glaucoma meds at 9am, 1pm, and 5pm <br>Post SLT IOP at 1day, 1week, and every 3 months for 2 years (IOP will be measured at 9am, 1pm, and 5pm at 1 month, 3 months, 6 months, 1 year and 2 years) <br>;Timepoint(s) of evaluation of this end point: 1day, 1week, and every 3 months for 2 years
- Secondary Outcome Measures
Name Time Method Secondary end point(s): Number of glaucoma meds pre-SLT and IOP with meds;Timepoint(s) of evaluation of this end point: n/a